BioMedomics Inc:企業の製品パイプライン分析2018

◆英語タイトル:BioMedomics Inc - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12757
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube based POC platform. It offers products such as alpha-thal scan, rapid diagnostic test for alpha-thalassemia; sickle scan, rapid diagnostic test for sickle cell disease and trait; and others. The company’s pipeline products are used for treating Troponin, vitamin D deficiency and testosterone deficiency. BioMedomics is headquartered in Durham, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BioMedomics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
BioMedomics Inc Company Overview 4
BioMedomics Inc Company Snapshot 4
BioMedomics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
BioMedomics Inc – Pipeline Analysis Overview 7
BioMedomics Inc – Key Facts 7
BioMedomics Inc – Major Products and Services 8
BioMedomics Inc Pipeline Products by Development Stage 9
BioMedomics Inc Pipeline Products Overview 11
CLIA-Waived Point of Care Test – Testosterone 11
CLIA-Waived Point of Care Test – Testosterone Product Overview 11
CLIA-Waived Point of Care Test – Vitamin D 12
CLIA-Waived Point of Care Test – Vitamin D Product Overview 12
Next Generation POC Reader 13
Next Generation POC Reader Product Overview 13
Point of Care Test – Troponin 14
Point of Care Test – Troponin Product Overview 14
Rapid Drug Overdose Test – Cocaine 15
Rapid Drug Overdose Test – Cocaine Product Overview 15
Rapid Drug Overdose Test – Methamphetamine 16
Rapid Drug Overdose Test – Methamphetamine Product Overview 16
Rapid Drug Overdose Test – Morphine 17
Rapid Drug Overdose Test – Morphine Product Overview 17
Rapid Drug Overdose Test – PCP 18
Rapid Drug Overdose Test – PCP Product Overview 18
Rapid Drug Overdose Test – THC 19
Rapid Drug Overdose Test – THC Product Overview 19
Rapid Quantitative Acetaminophen Detection Assay 20
Rapid Quantitative Acetaminophen Detection Assay Product Overview 20
Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test 21
Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test Product Overview 21
Sickle SCAN 22
Sickle SCAN Product Overview 22
TR-LFIA Diagnostic Platform 23
TR-LFIA Diagnostic Platform Product Overview 23
BioMedomics Inc – Key Competitors 24
BioMedomics Inc – Key Employees 25
BioMedomics Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
BioMedomics Inc, Recent Developments 27
Sep 22, 2015: Sickle SCAN Successfully Validated in Laboratory Testing 27
Aug 13, 2015: BioMedomics Receives CE Mark Approval for alpha-Thal SCAN 27
Feb 13, 2015: BioMedomics Receives CE Mark Approval for Sickle SCAN 27
Appendix 28
Methodology 28
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
BioMedomics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
BioMedomics Inc Pipeline Products by Equipment Type 5
BioMedomics Inc Pipeline Products by Indication 6
BioMedomics Inc, Key Facts 7
BioMedomics Inc, Major Products and Services 8
BioMedomics Inc Number of Pipeline Products by Development Stage 9
BioMedomics Inc Pipeline Products Summary by Development Stage 10
CLIA-Waived Point of Care Test - Testosterone - Product Status 11
CLIA-Waived Point of Care Test - Testosterone - Product Description 11
CLIA-Waived Point of Care Test - Vitamin D - Product Status 12
CLIA-Waived Point of Care Test - Vitamin D - Product Description 12
Next Generation POC Reader - Product Status 13
Next Generation POC Reader - Product Description 13
Point of Care Test - Troponin - Product Status 14
Point of Care Test - Troponin - Product Description 14
Rapid Drug Overdose Test - Cocaine - Product Status 15
Rapid Drug Overdose Test - Cocaine - Product Description 15
Rapid Drug Overdose Test - Methamphetamine - Product Status 16
Rapid Drug Overdose Test - Methamphetamine - Product Description 16
Rapid Drug Overdose Test - Morphine - Product Status 17
Rapid Drug Overdose Test - Morphine - Product Description 17
Rapid Drug Overdose Test - PCP - Product Status 18
Rapid Drug Overdose Test - PCP - Product Description 18
Rapid Drug Overdose Test - THC - Product Status 19
Rapid Drug Overdose Test - THC - Product Description 19
Rapid Quantitative Acetaminophen Detection Assay - Product Status 20
Rapid Quantitative Acetaminophen Detection Assay - Product Description 20
Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test - Product Status 21
Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test - Product Description 21
Sickle SCAN - Product Status 22
Sickle SCAN - Product Description 22
TR-LFIA Diagnostic Platform - Product Status 23
TR-LFIA Diagnostic Platform - Product Description 23
BioMedomics Inc, Key Employees 25
Glossary 30

List of Figures
BioMedomics Inc Pipeline Products by Equipment Type 5
BioMedomics Inc Pipeline Products by Development Stage 9

★海外企業調査レポート[BioMedomics Inc:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SOL SpA (SOL):企業財務及び戦略的SWOT分析
    Summary SOL SpA (SOL), a subsidiary of Gas and Technologies World BV is a chemical company that research, produces and distributes industrial, pure and medicinal gases. The company’s technical gases include oxygen, nitrogen, argon, hydrogen, carbon dioxide, acetylene, nitrous oxide, gas mixtures, hi …
  • Career Education Corporation:企業の戦略・SWOT・財務情報
    Career Education Corporation - Strategy, SWOT and Corporate Finance Report Summary Career Education Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Evolution Petroleum Corp (EPM):石油・ガス:M&Aディール及び事業提携情報
    Summary Evolution Petroleum Corp (EPC), a subsidiary of Esrey Resources Ltd, is an oil and gas company that acquires and explores crude oil and natural gas properties. The company explores for oil, liquefied gas, natural gas, and gas reserves in Delhi field CO2-EOR project. It offers GARP or gas ass …
  • Sumitomo Electric Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Fidelity Life Assurance of Zimbabwe Ltd:企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Rashtriya Ispat Nigam Limited:企業のM&A・提携動向(エネルギー分野)
    Summary Rashtriya Ispat Nigam Limited (RINL) is a steel manufacturing company that produces steel. The company's products include steel, plain wire rods in colis, Vizag TMT rebars, structurals, plain rounds, by products and forged rounds. It caters to the requirements of construction, manufacturing …
  • Hidd Power Company (BSC):企業概要及び戦略的SWOT分析
    Hidd Power Company (BSC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Air Transport Group Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Air Transport Group Holdings, I …
  • Beckman Coulter Genomics Inc.(製薬・医療分野):企業M&A動向
    Summary Beckman Coulter Genomics Inc. (Beckman Coulter) is a genomic service provider. The company provides genomics solutions to life science, healthcare, academic and government institutions. Its services include next generation sequencing, Sanger DNA sequencing and bioinformatics. Beckman Coulter …
  • Kepler Weber S.A. (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber S.A. (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Guizhou Yi Bai pharmaceutical Co., Ltd. (600594):企業の財務及び戦略的SWOT分析
    Summary Guizhou Yi Bai pharmaceutical Co., Ltd. (YiBai) is a pharmaceutical company that research new drugs. The company conducts research, develops, produces, and markets pharmaceutical products including tumor system drugs, circulatory system drugs, respiratory medicine, rheumatoid bone drug, and …
  • Innopharmax Inc. (4172):企業概要、財務及び戦略的SWOT分析
    Summary Innopharmax Inc. (InnoPharmax) is a specialty pharmaceutical company. The company develops and commercializes products for the treatment of infectious diseases, immunology and oncology. It also focuses on developing and acquiring potential drug candidates for further clinical development. In …
  • Trinity Biotech Plc (TRIB):企業のM&A・提携動向(医療機器分野)
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company. It develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The Clinical Laboratory products include diagnostic tests and instruments that detect infectious dis …
  • Consolidated Edison, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Consolidated Edison, Inc. Merge …
  • Armune BioScience Inc-医療機器分野:企業M&A・提携分析
    Summary Armune BioScience Inc (Armune) is a medical device company that develops and commercializes molecular diagnostic and prognostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests fo …
  • Celestica Inc.:企業の戦略・SWOT・財務分析
    Celestica Inc. - Strategy, SWOT and Corporate Finance Report Summary Celestica Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • WPP Digital:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' WPP Digital Mergers and Acquisi …
  • Paramount Resources Ltd. (PRMRF):企業概要、財務及び戦略的SWOT分析
    Summary Paramount Resources Ltd. (Paramount Resources) is an independent energy company. It specializes in the exploration, development, production, and marketing of crude oil, natural gas, and natural gas liquids (NGLs) in Alberta, British Columbia, Saskatchewan and the Northwest Territories. The c …
  • Pacific Environment Limited (PEH):企業の財務及び戦略的SWOT分析
    Summary Pacific Environment Limited (PEL) is an environmental consultancy service provider that offers environmental consulting, monitoring, automated reporting and predictive management solutions. The company offers services such as air quality and meteorology, ambient and fugitive monitoring, audi …
  • Axel Springer SE:企業の戦略・SWOT・財務情報
    Axel Springer SE - Strategy, SWOT and Corporate Finance Report Summary Axel Springer SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆